3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Conditions
Polycystic Ovary Syndrome
3
Uterine Anomalies
1
Salpingitis
1
Prostatic Neoplasms
1
Progesterone Resistance
1
Primary Ovarian Insufficiency
1
Pregnancy, Ectopic
1
Obesity
1
Leiomyoma
1
Infertility, Female
1
Infertility
1
Hypertension
1
Endometritis
1
Endometriosis
1
Endometrial Neoplasms
1
Endometrial Hyperplasia
1
Interventions
Clomiphene
18
Metformin
12
Letrozole
11
Triptorelin Pamoate
7
cetrorelix
5
Menotropins
5
Chorionic Gonadotropin
4
Surveys and Questionnaires
3
Sperm Injections, Intracytoplasmic
3
Medroxyprogesterone Acetate
3
Gonadotropins
3
Folic Acid
3
Uterine Myomectomy
2
Tamoxifen
2
Sugars
2
Progestins
2
Liraglutide
2
Inositol
2
High-Energy Shock Waves
2
Flutamide
2
ulipristal acetate
1
testosterone undecanoate
1
methyl N-acetylsibirosaminide
1
hMG-IBSA
1
follitropin alfa
1
drospirenone and ethinyl estradiol combination
1
drospirenone
1
Thyrotropin
1
Thioctic Acid
1
Therapeutics
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Infertility
×
LHRH, Ac-Nal(1)-Cpa(2)-Trp(3)-Arg(6)-Ala(10)-
×
Clear all
NCT04071574
2023-05-09
CS-EOSP-ICSI
Lebanese University
Phase 1/2
Completed
200 enrolled